Kits Eyecare Reports $159.3 Million In Prelim Revenue For 2024
Kits Eyecare (TSX: KITS) has released preliminary results for the fourth quarter as well as the full year of 2024. The results are highlighted by topline revenue growth of 32% on a year over year basis.
Total revenue for the fourth quarter is reported as being $44.8 million, marking a 42% improvement on a year over year basis. Glasses revenue is said to have been a key aspect of this growth, with the segment seeing 60% growth on a year over year basis.
Adjusted EBITDA also improved in Q4, with Kits indicating that it exceeded 6% of revenue while not providing an actual dollar figure. At 6%, Adjusted EBITDA would be approximately $2.7 million.
The company is said to have ended the quarter with $19.3 million in cash, versus $19.1 million in cash as of the end of the third quarter.
For the full fiscal year, revenue grew 32% to $159.3 million. Adjusted EBITDA is said to have exceeded 4% of revenue on a full year basis, with the company again electing to not provide a dollar figure. At 4%, this figure is estimated at roughly $6.4 million.
Full financial results are slated to be released in early March.
Kits Eyecare last traded at $7.90 on the TSX.
Information for this story was found via the sources mentioned within the article. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.